Tonix Q3 2025 Earnings Recap And Tonmya Launch Outlook (NASDAQ:TNXP)

Tonix Pharmaceuticals Holding Corp. ( TNXP ) reported 3Q25 earnings back on the 10th of November, and the market reaction was pretty lukewarm. GAAP EPS came in at –$3.59, missing consensus by just $0.01 on revenue of $3.29 million, whichI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave m ...